← 홈

고형암 (전체)

791개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 791개
CGTBiologicstaleChristian HinrichsPhase 2

E7 TCR-T cells (E7 TCR-T cells)

HPV-Associated Cervical Carcinoma; HPV-Related Carcinoma · HPV-Associated Cervical Carcinoma

#HPV-AssociatedCervicalCarcinoma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 5%임상시험 2상태 RECRUITING
AntibodystaleMacroGenicsPhase 3

Enoblituzumab (Enoblituzumab)

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 6%임상시험 2상태 DISCONTINUED
ADCBiologicstaleDavid OhPhase 2

Etrumadenant (Etrumadenant)

Prostate Adenocarcinoma; Prostate Cancer · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicstaleBioAtla, Inc.Phase 2

BA3071 (Evalstotug, Evalstotug (BA3071))

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FDA018-ADC (FDA018-ADC)

Advanced/ Metastatic Solid Tumors · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 2

FDA022-BB05 (FDA022-BB05)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 1

FPI-2053 (FPI-2053)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicstaleHRYZ Biotech Co.Phase 1

HRYZ-T101 TCR-T Cell (HRYZ-T101 TCR-T Cell)

Cervical Cancer; Head and Neck Squamous Cell Carcinoma · Cervical Cancer

#CervicalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
ADCBiologicstaleAbbViePhase 1

IMGN151 (IMGN151)

Endometrial Cancer; High Grade Serous Adenocarcinoma of Ovary · Endometrial Cancer

#EndometrialCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
CGTBiologicstaleSeigo NishidaPhase 1

Liver NK cell inoculation (Liver NK cell inoculation)

Liver Cirrhosis; Hepatocellular Carcinoma · Liver Cirrhosis

#LiverCirrhosis#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
ADCBiologicstaleEMD Serono Research & Developme…Phase 2

M6223 (M6223)

Metastatic Solid Tumors · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleMenarini GroupPhase 1

MEN1309 (MEN1309)

Metastatic Solid Tumors; Relapsed/Refractory Non-Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 DISCONTINUED
ADCBiologicstaleLepu Biopharma Co., Ltd.Phase 2

MRG006A (MRG006A)

Hepatocellular Carcinoma · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleMerck KGaAPhase 1

Methotrexate/Vinblastine/Doxorubicin/Cisplatin/Avelumab (Methotrexate/Vinblastine/Doxorubicin/Cisplatin/Avelumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#Antibody#Phase1#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Niraparib + Nivolumab)

Pancreatic Adenocarcinoma · Pancreatic Adenocarcinoma

#PancreaticAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 7.7%임상시험 2상태 ACTIVE
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

OMTX705 (OMTX705)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
AntibodystaleBeiGenePhase 3

Ociperlimab (Ociperlimab)

Advanced Hepatocellular Carcinoma · FRα

#FR#Antibody#Phase3#항체#면역항체+3
효능 ORR 100%임상시험 2상태 DISCONTINUED

16 / 40 페이지

← 이전다음 →